2024-10-08 – Press Releases – www.prnewswire.com
SAN FRANCISCO and SUZHOU, China, Oct. 8, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and…